Chapter
The Exciting Future of Psychedelic Research
47:13 - 58:20 (11:06)
The speaker discusses the potential for breakthroughs in psychedelic research and the need for clinical trials with lightly active placebos. Philanthropic funding has been important in jumpstarting this field of research and securing government grants.
Clips
It is difficult to incorporate placebo controls in psychedelic studies, especially when dealing with larger doses of psilocybin or LSD, and there may be a need for lightly active placebos when conducting clinical trials.
47:13 - 54:49 (07:35)
Summary
It is difficult to incorporate placebo controls in psychedelic studies, especially when dealing with larger doses of psilocybin or LSD, and there may be a need for lightly active placebos when conducting clinical trials. The high ceilings for lethal doses of these compounds in comparison to acetaminophen suggest that the punishment for drug-related offenses might be too harsh.
ChapterThe Exciting Future of Psychedelic Research
Episode#619: Dr. Suresh Muthukumaraswamy — LSD Microdosing, Classical Psychedelics vs. Ketamine, Science and Speed in New Zealand, Placebo Options, and The Infinite Possibilities of Studying Mind-Altering Compounds
PodcastThe Tim Ferriss Show
The speakers discuss the important role philanthropic funding plays in seed money for research and how government support can accelerate progress and establish them as leaders in the field.
54:49 - 58:20 (03:30)
Summary
The speakers discuss the important role philanthropic funding plays in seed money for research and how government support can accelerate progress and establish them as leaders in the field.